Updates on Trichodysplasia Spinulosa Disease
April 2026
in “
Reviews in Medical Virology
”
Studysummary This review discusses recent updates on trichodysplasia spinulosa, focusing on its seroepidemiology, mechanisms, and treatment options, and reports no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.
Trichodysplasia spinulosa (TS) is a rare condition linked to immunosuppression, characterized by keratin spicules and potential progression to alopecia and a leonine face. Fewer than 100 cases have been documented, mostly in solid organ transplant patients. The infection mechanism of the causative Trichodysplasia spinulosa-associated polyomavirus (TSPyV) is not well understood, although 75% of adults have antibodies against it, and it is transiently present in about 1% of the population. Recent updates over the past 5 years include studies on the virus's seroepidemiology, proliferation mechanisms, and treatment options.